Trademark: 88707194
Word
DOJOLVI
Status
Registered
Status Code
700
Status Date
Tuesday, November 10, 2020
Serial Number
88707194
Registration Number
6196836
Registration Date
Tuesday, November 10, 2020
Mark Type
3000
Filing Date
Tuesday, November 26, 2019
Published for Opposition
Tuesday, April 7, 2020

Trademark Owner History
Ultragenyx Pharmaceutical Inc. - Original Registrant

Classifications
5 Pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
The color(s) black, turquoise and lime green is/are claimed as a feature of the mark.
The mark consists of the "DOJOLVI" trademark in black sans serif capital letters in which the first "O" is slightly vertically elevated relative to the other letters and is directly above two stacked quarter spheres. The top quarter sphere is turquoise and the lower quarter sphere is lime green.

Trademark Events
Nov 10, 2020
Registered-Principal Register
Oct 3, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 2, 2020
Allowed Principal Register - Sou Accepted
Sep 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 10, 2020
Statement Of Use Processing Complete
Aug 25, 2020
Use Amendment Filed
Sep 10, 2020
Extension 1 Granted
Aug 25, 2020
Extension 1 Filed
Sep 10, 2020
Case Assigned To Intent To Use Paralegal
Aug 25, 2020
Teas Extension Received
Aug 25, 2020
Teas Statement Of Use Received
Jun 2, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 7, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 7, 2020
Published For Opposition
Mar 18, 2020
Notification Of Notice Of Publication E-Mailed
Mar 2, 2020
Approved For Pub - Principal Register
Feb 28, 2020
Assigned To Examiner
Dec 4, 2019
Notice Of Design Search Code E-Mailed
Dec 3, 2019
New Application Office Supplied Data Entered In Tram
Nov 29, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24